Steven Fineberg, MD, presented the study at the International Society for the Study of Lumbar Spine Meeting.
BMP is used in more than half of the anterior lumbar fusions in the U.S. and about one third of posterior lumbar fusions. Patients receiving the drug are typically younger with fewer comorbidities, according to the report.
More Articles on Devices:
Benvenue Medical Concludes Patient Follow-Ups in Orthopedic Device Clinical Trial
Medtronic to Eliminate 2k Jobs Worldwide
Blue Belt Technologies, DJO Surgical Partner for Knee Implant System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
